A record of what PL Capital Analysis said publicly, with the source. Not advice.
Pending — not yet graded
“PL Capital is overweight on the Healthcare sector, increasing weights in Sun Pharmaceutical Industries and identifying Hospitals as an emerging theme. They anticipate strong EBITDA growth to continue in the Hospitals and Pharma sectors.”
PL Capital Analysis’s track record (trackable calls only): 19 graded calls · 95% CI 51–88%
Nifty Healthcare IndexBullishCalled 17 Oct 2024
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee PL Capital Analysis’s full track record